Reproductive Genetics is the branch of science that deals with the relationship between reproduction and genotype. It involves various tests and procedures to offer needful information about the probabilities of having a child in case of any specific genetic disorder. Moreover, Reproductive Genetics further help predict & prevent genetic disorders during reproductive procedures.
The “Global Reproductive Genetics Market” is likely to grow at a CAGR of around 12% during the forecast period, i.e., 2021-26, says MarkNtel Advisors. The market growth primarily attributes to molecular diagnostics and rising awareness regarding genetic testing & screenings. With technological advancements, genetic tests are gaining excellent popularity in reproductive procedures.
They assist in identifying the cause of infertility & carriers of inherited diseases, thereby helping in directing toward the most suitable assisted reproductive techniques. Hence, these factors are likely to fuel the Global Reproductive Genetics Market in the coming years
The research report, “Global Reproductive Genetics Market Analysis, 2021,” depicts a deep-dive market analysis of market statistics, including regional & country-wise market size, market forecast, CAGR & market share of different segments, competitive benchmarking, and key market drivers & restraints.
|Study Period||Historical Data: 2016-19|
|Base Year: 2020|
|Forecast Period: 2021-26|
|Regions Covered||North America: USA, Canada, Mexico|
|Europe: Germany, The UK, France, Spain, Italy|
|Asia-Pacific: China, India, Japan, South Korea, Australia|
|South America: Brazil, and Argentina|
|Key Companies Profiled||ThermoFisher Scientific, Eurofins Scientific SE, Natera Inc., BGI Genomics, Illumina, Inc., Agilent Technologies, Inc., CENTOGENE AG, Fulgent Genetics, Inc., F. Hoffmann-La Roche Ltd, Invitae Corporation, Laboratory Corporation of America Holdings, PerkinElmer, Inc., Myriad Genetics, Inc., OPKO Health, Inc., Quest Diagnostics, QIAGEN NV|
|Unit Denominations||USD Million/Billion|
COVID-19 Outbreak Negatively Impacted the Global Reproductive Genetics Market
The outbreak of the COVID-19 pandemic has resulted in the governments of different nations enforcing strict movement restrictions and the shutdown of clinics. During this time, consumers shifted their preferences toward tele consulting to avoid the risk of getting infected.
Additionally, the shortage of skilled human resources, infrastructure, and logistic issues also affected the overall healthcare system. The situation worsened further due to reduced access & decline in genetic testing globally owing to the extended lockdown in all regions.
However, reproductive genetic testing companies incorporated several measures, including supply chain centralization, to recover from the losses caused by the pandemic. Hence, the market shall regain its usual pace and attain significant growth in the forecast period.